Drugmaker Sanofi-Aventis gave millions of dollars to two medical societies which urged the U.S. Food and Drug Administration to delay approving a low-cost version of the company's blockbuster blood thinner, according to a Senate investigation.
Senate: Sanofi petitioned doc groups
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.